These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 9067271)

  • 1. Loss of heterozygosity at chromosome 16q in prostate adenocarcinoma: identification of three independent regions.
    Latil A; Cussenot O; Fournier G; Driouch K; Lidereau R
    Cancer Res; 1997 Mar; 57(6):1058-62. PubMed ID: 9067271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three distinct commonly deleted regions of chromosome arm 16q in human primary and metastatic prostate cancers.
    Suzuki H; Komiya A; Emi M; Kuramochi H; Shiraishi T; Yatani R; Shimazaki J
    Genes Chromosomes Cancer; 1996 Dec; 17(4):225-33. PubMed ID: 8946204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of heterozygosity in chromosomal region 16q24.3 associated with progression of prostate cancer.
    Härkönen P; Kyllönen AP; Nordling S; Vihko P
    Prostate; 2005 Feb; 62(3):267-74. PubMed ID: 15389780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A widely expressed transcription factor with multiple DNA sequence specificity, CTCF, is localized at chromosome segment 16q22.1 within one of the smallest regions of overlap for common deletions in breast and prostate cancers.
    Filippova GN; Lindblom A; Meincke LJ; Klenova EM; Neiman PE; Collins SJ; Doggett NA; Lobanenkov VV
    Genes Chromosomes Cancer; 1998 May; 22(1):26-36. PubMed ID: 9591631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of heterozygosity at 16q24.1-q24.2 is significantly associated with metastatic and aggressive behavior of prostate cancer.
    Elo JP; Härkönen P; Kyllönen AP; Lukkarinen O; Poutanen M; Vihko R; Vihko P
    Cancer Res; 1997 Aug; 57(16):3356-9. PubMed ID: 9269995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allelic loss at 16q23.2 is associated with good prognosis in high grade prostate cancer.
    Fromont G; Valeri A; Cher M; Pontes JE; Vallancien G; Validire P; Latil A; Cussenot O
    Prostate; 2005 Dec; 65(4):341-6. PubMed ID: 16015610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of heterozygosity mapping at chromosome arm 16q in 712 breast tumors reveals factors that influence delineation of candidate regions.
    Cleton-Jansen AM; Callen DF; Seshadri R; Goldup S; Mccallum B; Crawford J; Powell JA; Settasatian C; van Beerendonk H; Moerland EW; Smit VT; Harris WH; Millis R; Morgan NV; Barnes D; Mathew CG; Cornelisse CJ
    Cancer Res; 2001 Feb; 61(3):1171-7. PubMed ID: 11221848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of heterozygosity at 7q31 is a frequent and early event in prostate cancer.
    Latil A; Cussenot O; Fournier G; Baron JC; Lidereau R
    Clin Cancer Res; 1995 Nov; 1(11):1385-9. PubMed ID: 9815935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of heterozygosity on chromosomes 10 and 17 in clinically localized prostate carcinoma.
    Ittmann MM
    Prostate; 1996 May; 28(5):275-81. PubMed ID: 8610052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allelic loss in a minimal region on chromosome 16q24 is associated with vitreous seeding of retinoblastoma.
    Gratias S; Rieder H; Ullmann R; Klein-Hitpass L; Schneider S; Bölöni R; Kappler M; Lohmann DR
    Cancer Res; 2007 Jan; 67(1):408-16. PubMed ID: 17210724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extensive analysis of the 13q14 region in human prostate tumors: DNA analysis and quantitative expression of genes lying in the interval of deletion.
    Latil A; Chêne L; Mangin P; Fournier G; Berthon P; Cussenot O
    Prostate; 2003 Sep; 57(1):39-50. PubMed ID: 12886522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Limiting the location of putative human prostate cancer tumor suppressor genes on chromosome 18q.
    Yin Z; Babaian RJ; Troncoso P; Strom SS; Spitz MR; Caudell JJ; Stein JD; Kagan J
    Oncogene; 2001 Apr; 20(18):2273-80. PubMed ID: 11402322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct deleted regions on chromosome segment 16q23-24 associated with metastases in prostate cancer.
    Li C; Berx G; Larsson C; Auer G; Aspenblad U; Pan Y; Sundelin B; Ekman P; Nordenskjöld M; van Roy F; Bergerheim US
    Genes Chromosomes Cancer; 1999 Mar; 24(3):175-82. PubMed ID: 10451696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and characterization of proximal 6q deletions in prostate cancer.
    Cooney KA; Wetzel JC; Consolino CM; Wojno KJ
    Cancer Res; 1996 Sep; 56(18):4150-3. PubMed ID: 8797584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of allelic imbalance of chromosome arms 7q, 8p, 16q, and 18q in stage T3N0M0 prostate cancer.
    Jenkins R; Takahashi S; DeLacey K; Bergstralh E; Lieber M
    Genes Chromosomes Cancer; 1998 Feb; 21(2):131-43. PubMed ID: 9491325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allele loss on chromosome 16q24.2-qter occurs frequently in breast cancers irrespectively of differences in phenotype and extent of spread.
    Tsuda H; Callen DF; Fukutomi T; Nakamura Y; Hirohashi S
    Cancer Res; 1994 Jan; 54(2):513-7. PubMed ID: 8275489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of heterozygosity of the BRCA1 and other loci on chromosome 17q in human prostate cancer.
    Gao X; Zacharek A; Salkowski A; Grignon DJ; Sakr W; Porter AT; Honn KV
    Cancer Res; 1995 Mar; 55(5):1002-5. PubMed ID: 7866981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chromosome 16 allelic loss analysis of a large set of microdissected prostate carcinomas.
    Strup SE; Pozzatti RO; Florence CD; Emmert-Buck MR; Duray PH; Liotta LA; Bostwick DG; Linehan WM; Vocke CD
    J Urol; 1999 Aug; 162(2):590-4. PubMed ID: 10411092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deletion map of chromosome 16q in ductal carcinoma in situ of the breast: refining a putative tumor suppressor gene region.
    Chen T; Sahin A; Aldaz CM
    Cancer Res; 1996 Dec; 56(24):5605-9. PubMed ID: 8971163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of heterozygosity at 7q31.1 and 12p13-12 in advanced prostate cancer.
    Kawana Y; Ichikawa T; Suzuki H; Ueda T; Komiya A; Ichikawa Y; Furuya Y; Akakura K; Igarashi T; Ito H
    Prostate; 2002 Sep; 53(1):60-4. PubMed ID: 12210480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.